Diary - News All news PDC*line Pharma raises €4 million

PDC*line Pharma raises €4 million

PDC*line Pharma raises €4 million ($4.24M) in a first round and appoints Eric Halioua as president and CEO

Three Belgian investment funds and several specialized international business angels have participated in this round, which will allow the company’s cancer immunotherapy technology to reach the clinical proof of concept phase.

Read the press release

To go further...

See PDC*line Pharma profil

Headlines

Our members

DEINOVE benefits from the support of the French government, within the framework of the “France Relance” plan, to accelerate the development of new antimicrobials

March 11^th, 2021

Amoéba submits its biocide application in the USA

April 9^th, 2021

Tollys appoints Amina Zinaï, MD, as head of clinical development

April 12^th, 2021

All news